Management of primary aldosteronism: its complications and their outcomes after treatment.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Vascular Pharmacology

• Publication date

  2009-03-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/157016109787455716PMID 19356005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment.

  2012cited by this paper
• The Aldosteronoma Resolution Score: Predicting Complete Resolution of Hypertension After Adrenalectomy for Aldosteronoma

  2008cited by this paper
• Cardiovascular outcomes in patients with primary aldosteronism after treatment.

  2008cited by this paper
• A Comparison of the Aldosterone‐blocking Agents Eplerenone and Spironolactone

  2008cited by this paper
• Vascular Remodeling and Duration of Hypertension Predict Outcome of Adrenalectomy in Primary Aldosteronism Patients

  2008cited by this paper
• Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis.

  2008cited by this paper
• Diagnosis and management of primary aldosteronism

  2008cited by this paper
• A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function.

  2008cited by this paper
• Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes.

  2008cited by this paper
• Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism

  2008cited by this paper
• SELECTION OF PATIENTS FOR SURGERY FOR PRIMARY ALDOSTERONISM

  2008cited by this paper
• Primary aldosteronism: cardiovascular, renal and metabolic implications.

  2008cited by this paper
• Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.

  2008cited by this paper
• Primary aldosteronism: renaissance of a syndrome

  2007cited by this paper
• Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure

  2007cited by this paper
• Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study

  2007cited by this paper
• Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment

  2007cited by this paper
• Increased intima–media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension

  2007cited by this paper
• Renal Damage in Primary Aldosteronism: Results of the PAPY Study

  2006cited by this paper
• Insulin sensitivity in patients with primary aldosteronism: a follow-up study.

  2006cited by this paper
• QT interval in patients with primary aldosteronism and low-renin essential hypertension

  2006cited by this paper
• The pharmacological treatment of primary aldosteronism

  2006cited by this paper
• Long-term renal outcomes in patients with primary aldosteronism.

  2006cited by this paper
• Clinical Characteristics of Aldosterone-Producing Microadenoma, Macroadenoma, and Idiopathic Hyperaldosteronism in 93 Patients with Primary Aldosteronism

  2006cited by this paper
• Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

  2006cited by this paper
• A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

  2006cited by this paper
• Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium Homeostasis

  2005cited by this paper
• The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.

  2005cited by this paper
• Relative glomerular hyperfiltration in primary aldosteronism.

  2005cited by this paper
• Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

  2005cited by this paper
• Long-Term Results of Adrenalectomy in Patients with Aldosterone-Producing Adenomas: Multivariate Analysis of Factors Affecting Unresolved Hypertension and Review of the Literature

  2005cited by this paper
• Beneficial impact of spironolactone in diabetic nephropathy.

  2005cited by this paper
• Laparoscopic adrenalectomy

  2004cited by this paper
• Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

  2004cited by this paper
• Laparoscopic Approach Reduces Likelihood of Perioperative Complications in Patients Undergoing Adrenalectomy

  2004cited by this paper
• Cardiovascular endocrinology 1: aldosterone function in diabetes mellitus: effects on cardiovascular and renal disease.

  2003cited by this paper
• Eplerenone: Cardiovascular Protection

  2003cited by this paper
• Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases.

  2003cited by this paper
• Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy

  2003cited by this paper
• Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension.

  2003cited by this paper
• Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.

  2003cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension

  2002cited by this paper
• Excess ldosterone Is Associated With Alterations of Myocardial Texture in Primary Aldosteronism

  2002cited by this paper
• Primary Hyperaldosteronism in the Era of Laparoscopic Adrenalectomy

  2002cited by this paper
• Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery

  2001cited by this paper
• Pathophysiological effects of aldosterone in cardiovascular tissues.

  2001cited by this paper
• Aldosterone as a mediator of progressive renal dysfunction: evolving perspectives.

  2001cited by this paper
• Medical Management of Aldosterone-Producing Adenomas

  1999cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Relations between cardiac and vascular structure in patients with primary and secondary hypertension.

  1998cited by this paper
• Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?

  1998cited by this paper
• Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.

  1997cited by this paper
• Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures.

  1997cited by this paper
• Association of hypokalemia, aldosteronism, and renal cysts.

  1990cited by this paper
• The treatment of low-renin ("primary") hyperaldosteronism.

  1978cited by this paper
• Comparison of Surgery and Prolonged Spironolactone Therapy in Patients with Hypertension, Aldosterone Excess, and Low Plasma Renin

  1972cited by this paper
• Hypertension, the potassium ion and impaired carbohydrate tolerance.

  1965cited by this paper
• Primary aldosteronism.

  1955cited by this paper

• Irregularities of Coagulation in Hypertension

  2023cites this paper
• Relationship of plasma aldosterone levels and carbohydrate metabolism in heart failure with preserved ejection fraction

  2021cites this paper
• Predictive modeling of incident heart failure in subjects with newly diagnosed atrial fibrillation

  2019cites this paper
• Feline primary hyperaldosteronism: an emerging endocrine disease.

  2016cites this paper
• EVALUATION OF MICROALBUMINURIA, RENAL FUNCTION AND LIPID IN ESSENTIAL HYPERTENSION

  2015cites this paper
• The multifaceted mineralocorticoid receptor.

  2014cites this paper
• Secondary Diabetes: Clinical Considerations

  2014cites this paper
• Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Hypertensive Patients Attending a Tertiary Hospital in Calabar, Nigeria

  2014cites this paper
• Apport de l'orientation clinique dans le diagnostic des hypertensions arterielles endocriniennes

  2014cites this paper
• Biochemical parameters as indicators of antihypertensive efficacy of stem bark extract of Nauclea latifolia

  2013cites this paper
• PRIMARY ALDOSTERONISM IN PREGNANCY

  2012cites this paper
• Evolution features of hypertensive patients with primary aldosteronism - Prospective Study

  2012cites this paper
• Surgical Management of Primary Aldosteronism. Not Everything that Shines is Gold

  2012cites this paper
• Is High Modified Mallampati Score A Risk Factor for Arterial Hypertension

  2012cites this paper
• Prescription audit of antihypertensive medication at the outpatient pharmacy in Kenyatta national hospital

  2012cites this paper
• Treatment of primary aldosteronism: Where are we now?

  2011cites this paper
• Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor

  2011cites this paper
• The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin–angiotensin–aldosterone system, oxidative stress and endogenous digitalis in the brain

  2011cites this paper
• Simultaneous surgery for chronic aortic dissection and adrenal adenoma with primary aldosteronism

  2010cites this paper
• Endocrine hypertension: diagnosis and management of a complex clinical entity.

  2010cites this paper
• Feline primary hyperaldosteronism.

  2010cites this paper
• The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism

  2010cites this paper
• The treatment of primary hyperaldosteronism

  2010cites this paper
• Invited commentary.

  2010cites this paper